SCHEMBL27759502

SCHEMBL27759502

CC(=O)ON1C(N)N(C)C(=O)C1(c1ccccc1)c1ccc2c(c1)OCCN2C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 3/20 0.41
PTGES2 Q9H7Z7 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
TRPV1 Q8NER1 1/20 0.34
NOTUM Q6P988 1/20 0.34
POLB P06746 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PTGER3 P43115 1/20 0.34
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
ALDH1A1 P00352 1/20 0.33
KDM1A O60341 2/20 0.33
HDAC3 O15379 2/20 0.33
HDAC1 Q13547 2/20 0.33
HDAC7 Q8WUI4 2/20 0.33
HDAC2 Q92769 2/20 0.33
HDAC10 Q969S8 2/20 0.33
HDAC11 Q96DB2 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27759648 0.73 GYS1 (0.32)
SCHEMBL4524491 0.71 HDAC4 (0.39) HDAC4PTGES2SLC6A2SLC6A4SLC6A3
Acetic Acid SCHEMBL4524486 0.70 BACE1 (0.55)
SCHEMBL27739085 0.69 UCHL1 (0.35) NOTUM
SCHEMBL27749225 0.69 CTSD (0.37) POLBL3MBTL1ALDH1A1
SCHEMBL8237861 0.67 BACE1 (0.60)
SCHEMBL4528325 0.65 NOTUM (0.40) HDAC4PTGES2NOTUMPOLBL3MBTL1
SCHEMBL27728798 0.64 MAPT (0.36) HDAC2MAPTSYK
SCHEMBL4526548 0.63 HDAC4 (0.50) HDAC4PTGES2NOTUMPOLBL3MBTL1
SCHEMBL27728796 0.62 BACE1 (0.34) SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101360715-A Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer's disease, neurodegeneration and dementia ASTRAZENECA AB (SE) 2009-02-04 CN claimed
CN-101360715-A Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer's disease, neurodegeneration and dementia ASTRAZENECA AB (SE) 2009-02-04 CN disclosed